Erik Sørensen

Erik Sørensen

Auto-generated profile, based on publicly available information

Erik Sørensen

Department of Clinical Immunology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 April 2025 in Nature
Verified
Journal Article
Open access
KHKonstantinos Hatzikotoulas
Konstantinos Hatzikotoulas
LSLorraine Southam
Lorraine Southam
LSLilja Stefansdottir
Lilja Stefansdottir
CBCindy G. Boer
Cindy G. Boer
MMMerry-Lynn McDonald
Merry-Lynn McDonald
EZEleftheria Zeggini
Eleftheria Zeggini
Osteoarthritis is the third most rapidly growing health condition associated with disability, after dementia and diabetes1. By 2050, the total number of patients with osteoarthritis is estimated to reach 1 billion worldwide2. As no disease-modifying treatments exist for osteoarthritis, a better understanding of disease aetiopathology is urgently needed. Here we perform a genome-wide association study meta-analyses across up to 489,975 cases and 1,472,094 controls, establishing 962 independent associations, 513 of which have not been previously reported. Using single-cell multiomics data, we identify signal enrichment in embryonic skeletal development pathways. We integrate orthogonal lines of evidence, including transcriptome, proteome and epigenome profiles of primary joint tissues, and implicate 700 effector genes. Within these, we find rare coding-variant burden associations with effect sizes that are consistently higher than common frequency variant associations. We highlight eight biological processes in which we find convergent involvement of multiple effector genes, including the circadian clock, glial-cell-related processes and pathways with an established role in osteoarthritis (TGFβ, FGF, WNT, BMP and retinoic acid signalling, and extracellular matrix organization). We find that 10% of the effector genes express a protein that is the target of approved drugs, offering repurposing opportunities, which can accelerate translation.

4 March 2025 in Nature Genetics
Verified
Journal Article
Open access
PDF file
AHAlbert Henry
Albert Henry
XMXiaodong Mo
Xiaodong Mo
CFChris Finan
Chris Finan
MCMark D. Chaffin
Mark D. Chaffin
DSDoug Speed
Doug Speed
HCHERMES Consortium
HERMES Consortium
Heart failure (HF) is a major contributor to global morbidity and mortality. While distinct clinical subtypes, defined by etiology and left ventricular ejection fraction, are well recognized, their genetic determinants remain inadequately understood. In this study, we report a genome-wide association study of HF and its subtypes in a sample of 1.9 million individuals. A total of 153,174 individuals had HF, of whom 44,012 had a nonischemic etiology (ni-HF). A subset of patients with ni-HF were stratified based on left ventricular systolic function, where data were available, identifying 5,406 individuals with reduced ejection fraction and 3,841 with preserved ejection fraction. We identify 66 genetic loci associated with HF and its subtypes, 37 of which have not previously been reported. Using functionally informed gene prioritization methods, we predict effector genes for each identified locus, and map these to etiologic disease clusters through phenome-wide association analysis, network analysis and colocalization. Through heritability enrichment analysis, we highlight the role of extracardiac tissues in disease etiology. We then examine the differential associations of upstream risk factors with HF subtypes using Mendelian randomization. These findings extend our understanding of the mechanisms underlying HF etiology and may inform future approaches to prevention and treatment.

6 March 2025 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
CRCarolina Roselli
Carolina Roselli
ISIda Surakka
Ida Surakka
MOMorten Olesen
Morten Olesen
GSGardar Sveinbjornsson
Gardar Sveinbjornsson
NMNicholas A Marston
Nicholas A Marston
PEPatrick T Ellinor
Patrick T Ellinor

14 April 2025 in Nature Genetics
Verified
Journal Article
Open access
PDF file
SVSamvida S. Venkatesh
Samvida S. Venkatesh
LWLaura B. L. Wittemans
Laura B. L. Wittemans
DPDuncan S. Palmer
Duncan S. Palmer
NBNikolas A. Baya
Nikolas A. Baya
TFTeresa Ferreira
Teresa Ferreira
CLCecilia Lindgren
Cecilia Lindgren
Genome-wide association studies (GWASs) may help inform the etiology of infertility. Here, we perform GWAS meta-analyses across seven cohorts in up to 42,629 cases and 740,619 controls and identify 25 genetic risk loci for male and female infertility. We additionally identify up to 269 genetic loci associated with follicle-stimulating hormone, luteinizing hormone, estradiol and testosterone through sex-specific GWAS meta-analyses (n = 6,095–246,862). Exome sequencing analyses reveal that women carrying testosterone-lowering rare variants in some genes are at risk of infertility. However, we find no local or genome-wide genetic correlation between female infertility and reproductive hormones. While infertility is genetically correlated with endometriosis and polycystic ovary syndrome, we find limited genetic overlap between infertility and obesity. Finally, we show that the evolutionary persistence of infertility-risk alleles may be explained by directional selection. Taken together, we provide a comprehensive view of the genetic determinants of infertility across multiple diagnostic criteria.

29 October 2024 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
EIErna V. Ivarsdottir
Erna V. Ivarsdottir
JGJulius Gudmundsson
Julius Gudmundsson
VTVinicius Tragante
Vinicius Tragante
GSGardar Sveinbjornsson
Gardar Sveinbjornsson
SKSnaedis Kristmundsdottir
Snaedis Kristmundsdottir
KSKari Stefansson
Kari Stefansson

6 December 2024 in Journal of the American Academy of Dermatology
Verified
Journal Article
Open access
RARune Kjærsgaard Andersen
Rune Kjærsgaard Andersen
LSLilja Stefansdottir
Lilja Stefansdottir
PRPeter Theut Riis
Peter Theut Riis
GHGisli Halldorsson
Gisli Halldorsson
EFEgil Ferkingstad
Egil Ferkingstad
KSKari Stefansson
Kari Stefansson
The contributions of genetic and environmental risk factors to hidradenitis suppurativa (HS) are both poorly understood. To identify sequence variants that associate with HS and determine the contribution of environmental risk factors and inflammatory diseases to HS pathogenesis. A genome-wide association meta-analysis of 4814 HS cases (Denmark: 1977; Iceland: 1266; Finland: 800; UK: 569; and US: 202) and 1.2 million controls, searching for sequence variants associated with HS. We found 8 independent sequence variants associating with HS, 6 common and 2 rare (frequency <1%). Four associations point to candidate causal genes, NCSTN, PSENEN, WNT10A, and TMED10, that all map to the Notch and Wnt/β-catenin signaling pathways, involved in epidermal keratinization. Limited racial diversity may prevent identification of sequence variants of particular importance in non-Caucasian populations. These findings demonstrate that genes and pathways involved in epidermal keratinization are the genetic backbone of HS pathology.